Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Aytu BioPharma
(NASDAQ:AYTU)
Intraday
$2.67
-0.13
[-4.64%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$2.67
-0.13
[-4.64%]
Last update: 4:58PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Aytu BioPharma Stock (NASDAQ:AYTU)
Aytu BioPharma Stock (NASDAQ: AYTU)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 14, 2024
Aytu BioPharma Q2 2024 GAAP EPS $(0.04) Beats $(0.25) Estimate, Sales $22.93M Beat $21.75M Estimate
Benzinga Newsdesk
-
Feb 14, 2024, 4:16PM
Earnings Scheduled For February 14, 2024
Benzinga Insights
-
Feb 14, 2024, 4:48AM
Tuesday, February 13, 2024
Earnings Preview: Aytu BioPharma
Benzinga Insights
-
Feb 13, 2024, 2:02PM
Wednesday, November 22, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Nov 22, 2023, 4:31PM
Wednesday, November 15, 2023
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Nov 15, 2023, 2:04PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Nov 15, 2023, 12:31PM
Tuesday, November 14, 2023
Aytu BioPharma Q1 EPS $(1.48) Down From $(1.20) YoY, Sales $22.10M Miss $27.73M Estimate
Benzinga Newsdesk
-
Nov 14, 2023, 4:30PM
Earnings Scheduled For November 14, 2023
Benzinga Insights
-
Nov 14, 2023, 8:23AM
Monday, November 13, 2023
Aytu BioPharma's Earnings: A Preview
Benzinga Insights
-
Nov 13, 2023, 11:01AM
Monday, November 06, 2023
Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard
Chris Katje
-
Nov 6, 2023, 2:54PM
Thursday, October 26, 2023
Aytu BioPharma Announces Approval Of The Cotempla XR-ODT Manufacturing Site Transfer Prior Approval Supplement
Benzinga Newsdesk
-
Oct 26, 2023, 8:06AM
Thursday, September 28, 2023
Aytu Biopharma shares are trading higher after the company reported better-than-expected Q4 financial results.
Benzinga Newsdesk
-
Sep 28, 2023, 3:10PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Sep 28, 2023, 1:31PM
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Sep 28, 2023, 1:04PM
Reported September 27, Aytu BioPharma Q4 EPS $(0.59) Beats $(0.95) Estimate, Sales $30.73M Beat $27.69M Estimate
Happy Mohamed
-
Sep 28, 2023, 11:47AM
Wednesday, September 27, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Sep 27, 2023, 5:31PM
Earnings Scheduled For September 27, 2023
Benzinga Insights
-
Sep 27, 2023, 7:07AM
Tuesday, September 26, 2023
Earnings Outlook For Aytu BioPharma
Benzinga Insights
-
Sep 26, 2023, 10:02AM
Thursday, August 24, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Aug 24, 2023, 9:06AM
Monday, August 21, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Aug 21, 2023, 5:31PM
Friday, August 18, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Aug 18, 2023, 5:32PM
Wednesday, August 16, 2023
Aytu BioPharma Chief Commercial Officer Awarded $12K Worth of Stock Options
Benzinga Insights
-
Aug 16, 2023, 11:00AM
Chief Financial Officer at Aytu BioPharma Acquires Company Stock Options Worth 13,000 Shares
Benzinga Insights
-
Aug 16, 2023, 11:00AM
Aytu BioPharma Chief Operating Officer Awarded $12K Worth of Stock Options
Benzinga Insights
-
Aug 16, 2023, 11:00AM
Aytu BioPharma Chief Executive Officer Awarded $64K Worth of Stock Options
Benzinga Insights
-
Aug 16, 2023, 11:00AM
Chief Business Officer at Aytu BioPharma Acquires Company Stock Options Worth 7,000 Shares
Benzinga Insights
-
Aug 16, 2023, 11:00AM
Wednesday, August 09, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 11:00AM
Maxim Group Initiates Coverage On Aytu BioPharma with Buy Rating, Announces Price Target of $5
Benzinga Newsdesk
-
Aug 9, 2023, 8:41AM
Monday, July 31, 2023
Aytu BioPharma Announces Exclusive Agreement With Medomie Pharma Ltd. To Commercialize Adzenys XR-ODT And Cotempla XR-ODT In Israel And The Palestinian Authority
Happy Mohamed
-
Jul 31, 2023, 8:06AM
Monday, July 10, 2023
Aytu BioPharma Announces Submission Of Cotempla XR-ODT Manufacturing Site Transfer Prior Approval Supplement
Happy Mohamed
-
Jul 10, 2023, 8:08AM
Friday, June 16, 2023
Star Equity Holdings And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Lisa Levin
-
Jun 16, 2023, 7:09AM
Friday, June 09, 2023
Aytu BioPharma Announces Pricing Of $4M Public Offering Priced At-The-Market
Benzinga Newsdesk
-
Jun 9, 2023, 9:20AM
Wednesday, May 31, 2023
HC Wainwright & Co. Reiterates Buy on Aytu BioPharma, Maintains $20 Price Target
Benzinga Newsdesk
-
May 31, 2023, 7:13AM
Friday, May 26, 2023
Aytu BioPharma 13D Filing Shows Nantahala Capital Management, LLC Increased Stake In Co 7.2%
Happy Mohamed
-
May 26, 2023, 1:55PM
Thursday, May 11, 2023
Aytu BioPharma: Q3 Earnings Insights
Benzinga Insights
-
May 11, 2023, 4:15PM
Aytu BioPharma Q3 EPS $(1.93) Misses $(0.63) Estimate, Sales $22.73M Miss $28.00M Estimate
Benzinga Newsdesk
-
May 11, 2023, 4:12PM
Earnings Scheduled For May 11, 2023
Benzinga Insights
-
May 11, 2023, 9:58AM
Wednesday, May 10, 2023
A Preview Of Aytu BioPharma's Earnings
Benzinga Insights
-
May 10, 2023, 10:03AM
Friday, May 05, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
May 5, 2023, 1:54PM
Thursday, May 04, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
May 4, 2023, 12:29PM
Tuesday, May 02, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
May 2, 2023, 1:31PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
May 2, 2023, 9:06AM
Why BlackBerry Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
May 2, 2023, 8:08AM
Monday, May 01, 2023
Aytu BioPharma Subleases Portion Of Its Manufacturing Facility
Benzinga Newsdesk
-
May 1, 2023, 8:08AM
Thursday, April 27, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Apr 27, 2023, 9:06AM
Aytu BioPharma Announces FDA Approval Of Adzenys XR-ODT(R)Manufacturing Site Transfer
Happy Mohamed
-
Apr 27, 2023, 8:17AM
Monday, March 20, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Mar 20, 2023, 1:29PM
Monday, March 06, 2023
5 Value Stocks In The Healthcare Sector
Benzinga Insights
-
Mar 6, 2023, 9:43AM
Wednesday, February 22, 2023
Aytu BioPharma's Return On Capital Employed Insights
Benzinga Insights
-
Feb 22, 2023, 9:48AM
Tuesday, February 14, 2023
Aytu BioPharma Announces Delayed Filing Of Q2 Fiscal 2023 Financial Results
Happy Mohamed
-
Feb 14, 2023, 8:23AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch